4D Molecular Therapeutics Says US FDA Clears Its IND Application for Potential Geographic Atrophy Treatment
4D Molecular Therapeutics Says US FDA Clears Its IND Application for Potential Geographic Atrophy Treatment
4d分子治療公司表示，美國FDA已經批准其針對潛在地理性萎縮的治療工業化學工業化工業化工工藝的IND申請。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊